Biosimilars and Biobetters
Chinese Competitiveness in a Global Context
As established markets in North America and Europe become more mature companies are looking further afield for potential new areas of opportunity And as the competition for patient populations and cost pressures increase potential new locations to deliver clinical trials as well as other elements of the RD process are becoming highly sought after...
